Alerts will be sent to your verified email
Verify EmailSAILIFE
| 
                  Sai Life Sciences 
             | 
            
            
                  Divi's Lab 
             | 
            
            
                  Cohance Lifesciences 
             | 
            
        |
|---|---|---|---|
| 
          
            
            Operational Metrics
         
     | 
    
    
        
            |||
| 
          
            
                
                
                
                    
                
                 
            
            Financials
         
     | 
    
    
        
            |||
| 
          
            
                
                
                
                    
                
                 
            
            5 yr Average ROE
         
     | 
     
         
            5.08 % | 17.46 % | 22.91 % | 
| 
          
            
            5yr average Equity Multiplier
         
     | 
     
         
            2.18 | 1.2 | 1.35 | 
| 
          
            
            5yr Average Asset Turnover Ratio
         
     | 
     
         
            0.51 | 0.55 | 0.56 | 
| 
          
            
            5yr Avg Net Profit Margin
         
     | 
     
         
            5.05 % | 25.76 % | 30.38 % | 
| 
          
            
            Price to Book
         
     | 
     
         
            9.1 | 12.07 | 16.76 | 
| 
          
            
            P/E
         
     | 
     
         
            113.79 | 78.35 | 111.05 | 
| 
          
            
                
                
                
                    
                
                 
            
            5yr Avg Cash Conversion Cycle
         
     | 
     
         
            -92.7 Days | 134.41 Days | 49.95 Days | 
| 
          
            
            Inventory Days
         
     | 
     
         
            32.39 Days | 121.85 Days | 74.21 Days | 
| 
          
            
            Days Receivable
         
     | 
     
         
            65.73 Days | 94.81 Days | 63.71 Days | 
| 
          
            
            Days Payable
         
     | 
     
         
            192.85 Days | 94.55 Days | 80.35 Days | 
| 
          
            
            5yr Average Interest Coverage Ratio
         
     | 
     
         
            2.4 | 1162.71 | 49.87 | 
| 
          
            
            5yr Avg ROCE
         
     | 
     
         
            9.14 % | 21.97 % | 27.5 % | 
| 
          
            
            5yr Avg Operating Profit Margin
         
     | 
     
         
            18.79 % | 34.94 % | 40.14 % | 
| 
          
            
            5 yr average Debt to Equity
         
     | 
     
         
            0.64 | 0.0 | 0.06 | 
| 
          
            
            5yr CAGR Net Profit
         
     | 
     
         
            22.73 % | 2.0 % | -5.86 % | 
| 
          
            
            5yr Average Return on Assets
         
     | 
     
         
            2.6 % | 14.47 % | 17.54 % | 
| 
          
            
                
                
                
                    
                
                 
            
            Shareholdings
         
     | 
    
    
        
            |||
| 
          
            
            Promoter Holding
         
     | 
     
         
            34.93 % | 51.89 % | 57.49 % | 
| 
          
            
            Share Pledged by Promoters
         
     | 
     
         
            0.0 | 0.0 | 0.0 | 
| 
          
            
            Change in Promoter Holding (3 Yrs)
         
     | 
     
         
            -0.31 % | -0.05 % | -2.51 % | 
| 
          
            
            Change in Mutual Fund Holding (3 Yrs)
         
     | 
     
         
            21.92 % | 0.37 % | 8.21 % | 
| 
                          Sai Life Sciences 
                     | 
                
                    
                          Divi's Lab 
                     | 
                
                    
                          Cohance Lifesciences 
                     | 
                
            |
|---|---|---|---|
| 
              
                Product Wise Break-Up
             
         | 
         
            
                
                    
                         Product Wise Break-Up 
                        
  | 
            
                
                    
                         Product Wise Break-Up 
                        
  | 
            
                
                    
                         Product Wise Break-Up 
                        
  | 
            
        
    
| 
              
                Location Wise Break-Up
             
         | 
         
            
                
                    
                         Location Wise Break-Up 
                        
  | 
            
                
                    
                         Location Wise Break-Up 
                        
  | 
            
                
                    
                         Location Wise Break-Up 
                        
  | 
            
        
    
| 
              
                Asset Break-Up - Geography Wise
             
         | 
         
            
                
                    
                         Asset Break-Up - Geography Wise 
                        
  | 
            
                
                    
                         - 
                    
                 | 
            
                
                    
                         - 
                    
                 |